Sign Up to Receive the Latest Trading Tips and News from Prosper

    December 4, 2018

    Novelion Therapeutics Inc. In the News Today

    Novelion Therapeutics Inc. (NVLN) rose sharply after market close yesterday after a major shareholder advocated for the company to explore a potential sale to another company. Our classroom has had a position in NVLN for a while where we were looking for something like this to happen, but the move was short-lived so we were […]

    Read Article
    December 3, 2018

    Tesaro Gets Bought

    The equities markets had a slightly bullish inclination today. The healthcare Tesaro, Inc. (TSRO) was up over +58% today after news hit that the company was being bought out by GlaxoSmithKline (GSK). The buyout price is $75 per share in cash, which caused GSK stock to drop over -8%. Previously in mid-November, TSRO was up […]

    Read Article
    November 30, 2018

    Trade Talk Optimism Gives A Boost To the Markets

    The equities markets had a slightly bullish inclination today. The healthcare ETF XLV was up +0.7% a the time this content was created, whereas the biotech ETF IBB was up about +0.96%. The primary reason for the overall rise in the markets is likely the possibility of progress on trade negotiations between the United States […]

    Read Article
    November 29, 2018

    Tonix Pharmaceuticals May Have Played Their Cards Right

    Tonix Pharmaceuticals finally broke strongly to the upside today. As expected, there was pent-up speculative interest in the stock due to its recent reverse split. The stock had a 10:1 reverse split, after which it rose about $4 per share to a high of $9.60 at the time this content was created. Here is a […]

    Read Article
    November 27, 2018

    Aethlon Medical, Inc. Introduces Its Breakthrough Technology

    Aethlon Medical, Inc. was very bullish in the pre-market session. The company received breakthrough device designation from the FDA for their Hemopurifier, which is used for the treatment of cancer. According to a press release from the company, the device is a “first-in-class technology designed for the rapid depletion of cancer-promoting exosomes and life-threatening viruses”. […]

    Read Article
    November 26, 2018

    Strength Evident In the Biotech Sector

    The equities markets were quite erratic today, with the major indexes mostly trading in a narrow range. The healthcare sector ETF XLV was up about +1% for the session, and the biotech ETF IBB was up +1.39%, once again showing stronger recovery in biotech versus the overall healthcare sector. However, both ETFs traded in narrow […]

    Read Article
    November 20, 2018

    Warning For Novartis

    Novartis AG (NVS) was down sharply at the middle of the session after an FDA warning. The company’s drug, GILENYA, was warned to cause severe worsening of M.S. symptoms once a patient discontinues use of the treatment. This caused the stock to drop sharply from just above $89 to nearly $86. The stock closed the […]

    Read Article
    November 19, 2018

    Tesaro Spikes On Buyout Rumors

    Tesaro (TSRO) spiked sharply in trading today after news that the company canceled an upcoming conference. The cancellation of the upcoming investor conference is seen as potential evidence that the company might be in the process of completing a merger. If this is the case, then shares are likely to head significantly higher if a […]

    Read Article
    November 16, 2018

    Have the Bulls Returned To Biotech?

    Today’s market had a clear bullish inclination, particularly in the overall healthcare sector. The sector ETF XLV was up over +0.90%, but the biotech ETF IBB lagged behind at +0.61%. We saw very strong movement in MRK, which was up over +1.40% and reached a high of $76.10 as of the time this content was […]

    Read Article
    November 15, 2018

    Trade Rumors Set the Tone For the Market

    The equities markets saw a bullish trend towards the end of today’s session after it was implied that the US and China might reach some tentative agreement on trade by the end of this year. However, shortly after this headline hit the newswires, a senior US trade official stated that such a deal was not […]

    Read Article